Regulatory Due Diligence for Pharmaceutical and Biologics Company Transactions

This practice note discusses some of the key legal and regulatory issues to evaluate, questions to ask, and documents to review in mergers, acquisitions, investments, financings, and other transactions involving pharmaceutical or biological products.